Results for 'cancer drug'
Rebecca Previs
Rethinking How We Track and Treat Cancer
Labcorp, Rebecca Previs, Michelle Green, genomics, ASCO, HER2, HER3, MRD, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, ctDNA, biomarker
HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.
Jul 13th • 19 mins listen
Kirk Shepard
Breakthroughs in Oncology Drug Development with Dr. Roy Baynes
How do world-changing cancer treatments go from concept to reality? Tune in and discover how strategy, leadership, and heart unite to change lives in oncology—listen now.
Mar 31st • 28 mins listen
Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care
Jay Fine, Preclinical Research, Early Stage
In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.
Feb 17th • 23 mins listen
Michael Pietrack
How to Accelerate Cancer Cures Through Collaboration with Kirk V. Shepard, MD
Kirk Shepard, Michael Pietrack, mentor, AI, digital
Join host Michael Pietrack on the PharmaVerse Podcast as he speaks with Dr. Kirk Shepard, Chief Medical Officer of PDS Biotechnology, co-founder of the Medical Affairs Professional Society (MAPS), and creator of the Oncology Voices Network (OVN).
Feb 2nd • 24 mins listen
Kirk Shepard
Trust, Transparency & Timelines: Advancing Cancer Care
Kirk Shepard, Rebecca Goldstein
In episode 2 of the Oncology Voice Network Podcast, Rebecca Goldstein joins Dr. Kirk Shepard to share her vision for the OVN community: a space where real collaboration happens between manufacturers and innovation partners, and both sides learn how to optimize this critical relationship. This is abo…
Feb 3rd • 24 mins listen
Ramin Farhood
Busting Silos: Building the Future of Oncology Drug Development
In our premiere episode, Dr. Ramin Farhood, along with Dr. Kirk Shepard, shares the origin story behind the Oncology Voice Network (OVN)—a bold vision to unite pharma, biotech, academia, and advocacy, breaking down silos that have slowed progress for years.
Jan 20th • 33 mins listen
The Oncology Nursing Podcast
Oncology Clinical Trials and Drug Development
ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug…
Oct 16th • 38 mins listen
The Oncology Nursing Podcast
Monoclonal Antibodies to Treat Cancer and COVID-19
ONS member Donna Bydlon, BSN, RN, OCN®, network director of infusion services at St. Luke's University Hospital and Health Network in Bethlehem, PA, and member of the Greater Lehigh Valley ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss nursing co…
Jul 15th • 27 mins listen
Monty Pal
How a Bold Yes Became a Scientific Breakthrough
City of Hope, Monty Pal, Linda Malkas, AOH1996, Ana Olivia Healy
Dr. Linda Malkas shares the story behind AOH1996—how one bold “yes” led to a new cancer drug and a legacy built from love and science.
Jun 9th • 47 mins listen
Monty Pal
Movement as Medicine: The Science Reshaping Oncology
City of Hope, Monty Pal, Lee Jones, movement, exercise, holistic
In this episode of "On the Edge of Breakthrough: Voices of Cancer Research," host Dr. Monty Pal welcomes Dr. Lee Jones, Head of the Exercise Oncology Program in the Department of Medicine at City of Hope, to discuss how exercise science is helping reshape cancer treatment and care. Dr. Jones shares …
Oct 27th • 56 mins listen
The Oncology Nursing Podcast
Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs
CDER, FDA, Nurses, biomarker, immunomodulatory
Highlights From Today’s Episode “Full approval through the Center for Drug Evaluation and Research (CDER) and FDA means that those drugs have gone through the laboratory testing, human clinical trial testing, and very extensive clinical trials to make sure that they are effective and th…
Mar 30th • 53 mins listen